Investigation of The Apoptotic and Antiproliferative Effects of Boron on CCL-233 Human Colon Cancer Cells
- PMID: 34455718
- PMCID: PMC8405086
- DOI: 10.22074/cellj.2021.7259
Investigation of The Apoptotic and Antiproliferative Effects of Boron on CCL-233 Human Colon Cancer Cells
Abstract
Objective: Colorectal cancer is one of the most prevalent consequences of cancer-bound decease worldwide and it remains one of the leading outcomes of cancer-bound decease. Boron is an important mineral that acts significant function in various biological courses. Some important chemical properties of boric acid support its utility in the treatment of cancer. The aim of this study is to evaluate the antiproliferative effects of boric acid in colon cancer.
Materials and methods: This experimental study effect of different concentrations of boric acid on the CCl-233 human colon adenocarcinoma cell lines was investigated, by analyzing proliferation assay (proliferation was applied to the cells for 24, 48 and 72 hours). Proliferation assay was performed using CCK8 Assay Kit. Vascular endothelial growth factor (VEGF) and poly (ADP-) ribose polymerase (PARP) analyses were performed using Sun-Red Human (VEGF) ELISA Kit and Sun-Red Human (PARP) ELISA Kit, respectively.
Results: As a result of the studies, analysis of the cell viability showed that 50 mM boric acid decreased cell proliferation after 24, 48 and 72 hours. The maximal decrease in cell proliferation was found to occur at 48 hours. Therefore, PARP and VGEF analyses were performed at 48 hours. PARP values were significantly higher in cisplatin (P<0.05). In contrast, PARP levels were significantly lower (P<0.05) at two concentrations of boron (50-100 mM). In VEGF, analysis showed that boron levels were significantly different from cisplatin, but there was no significant difference between control groups.
Conclusion: It is proposed that the molecular mechanisms leading to this type of cancer as well as the effect of boric acid on colon cancer should be clarified in more detailed ways for the early diagnosis and treatment of colon cancer.
Keywords: Boric Acid; Colon Cancer; Poly (ADP-) Ribose Polymerase; Proliferation; Vascular Endothelial Growth Factor.
Copyright© by Royan Institute. All rights reserved.
Conflict of interest statement
There is no conflict of interest in this study.
Figures
Similar articles
-
Boric acid suppresses cell proliferation by TNF signaling pathway mediated apoptosis in SW-480 human colon cancer line.J Trace Elem Med Biol. 2022 May;71:126958. doi: 10.1016/j.jtemb.2022.126958. Epub 2022 Feb 19. J Trace Elem Med Biol. 2022. PMID: 35219976
-
Neuropilin-1 modulates vascular endothelial growth factor-induced poly(ADP-ribose)-polymerase leading to reduced cerebrovascular apoptosis.Neurobiol Dis. 2013 Nov;59:111-25. doi: 10.1016/j.nbd.2013.06.009. Epub 2013 Jun 28. Neurobiol Dis. 2013. PMID: 23816753
-
In vitro effects of boric acid on human liver hepatoma cell line (HepG2) at the half-maximal inhibitory concentration.J Trace Elem Med Biol. 2020 Dec;62:126573. doi: 10.1016/j.jtemb.2020.126573. Epub 2020 May 30. J Trace Elem Med Biol. 2020. PMID: 32534377
-
An assessment of boric acid and borax using the IEHR Evaluative Process for Assessing Human Developmental and Reproductive Toxicity of Agents. Expert Scientific Committee.Reprod Toxicol. 1997 Jan-Feb;11(1):123-60. doi: 10.1016/s0890-6238(96)00204-3. Reprod Toxicol. 1997. PMID: 9138630 Review.
-
Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.Cardiovasc Toxicol. 2018 Dec;18(6):493-506. doi: 10.1007/s12012-018-9462-2. Cardiovasc Toxicol. 2018. PMID: 29968072 Review.
References
-
- Gearhart S, Ahuja N. Early diagnosis and treatment of cancer series: colorectal cancer. 1st ed. Saunder: Elsevier Health Sciences; 2010. pp. 1–9.
-
- Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics. CA Cancer J Clin. 2005;55(2):74–108. - PubMed
-
- Lai SM, Zhang KB, Uhler RJ, Harrison JN, Clutter GG, Williams MA. Geographic variation in the incidence of colorectal cancer in the United States. Cancer. 2006;107(5):1172–1180. - PubMed
-
- Thompson M, Perera R, Senapati A, Dodds S. Predictive value of common symptom combinations in diagnosing colorectal cancer. Br J Surg. 2007;94(10):1260–1265. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials